bombshel quarter forecast launch yet
post jaw-drop revenu beat estim
street forecast preview forecast sizeabl beat felt
abbott neutral bring patient price pressur
yet begun addit co lift sale guidanc
expect post strong beat magnitud
out-performance impress particularli sinc includ
week launch increas sale forecast
outyear concern price come year remain
seem quarter beat bit lot everyth
driver includ intern sale new patient adopt
system increas awar cgm class seem continu
benefit sinc launch major factor
quarter expect result look healthi well
remain concern price find difficult pinpoint
time potenti impact sale copiou number
contract consid nearli imposs view determin
larg payor might decid make chang addit
patient access benefit move pharmaci channel
subscript model may outweigh potenti accompani price
pressur shift possibl price headwind
contempl guidanc think near-term impact
like limit beyond greater concern price
gross margin weak quarter acceler launch
manufactur push meet custom demand led higher
cost dynam expect continu start
improv view small price pay
right strategi busi
valuat rate neutral risk discuss
btig estim compani document million except per share amount
pleas read import disclosur analyst certif appear appendix
total revenu came forecast
gross margin bp model due manufactur
volum earli launch sg spend spend well
model bp bp lower respect net loss per
share cent better model
significantli increas patient add increas price near term reach
revenu guidanc curb gross margin increas oper
expens back half expect margin recov improv
higher forecast revenu outyear
actualsbtig estimate variancetot revenu net incom spend spend opex spend marginnmnmnmsourc btig estim compani filingsvari
rate neutral believ current multipl
estim ntm ev/sal expens given potenti slow growth
seem support investor concern
competit price like immedi and/or increas spend
expect exceed revenu estim wonder happen
price risk rate includ competit increas spend
chang revenu growth rate fda product recal reimburs
price pressur
bpsebit bp btig estim compani filingsnewold changentm inc ingnnot sciencesexasbuy medicalwmginot factset data btig estimatespr profitev/salescagrcompanytickerr ptpricemarket cap
incom product develop grant oper expens tax expens net incom share net incom net incom analysisgross profit net incom revenu oper oper btig estim compani report
revenu eworldwid patient basebegin new drop patient re-ord disclos histor patient price revenu re-ord disclos histor patient price revenu hardwar revenu sensor kit order per quarter disclos histor per sensor revenu product btig estim compani report
btig cover compani mention report
appendix analyst certif import disclosur
